Wednesday, September 7th, 2011
Physicians and patient groups welcome the National Institute for Health and Clinical Excellence (NICE) decision to reverse the draft guidance and approve the use of use of Mepact® in their latest appraisal, announced Takeda UK. Mepact® is designed to treat high-grade non-metastatic osteosarcoma in children, adolescents and young adults aged ...
Posted in Health | Comments Off
Wednesday, April 27th, 2011
The National Institute for Health and Clinical Excellence (NICE) has today issued final guidance recommending golimumab (Simponi) for the treatment of psoriatic arthritis. Golimumab joins a list of treatment options already recommended by NICE for this condition. The guidance recommends golimumab as an option for treating active and progressive psoriatic ...
Posted in Health | Comments Off
Sunday, December 12th, 2010
The National Institute for Health and Clinical Excellence (NICE) has opened its consultation on the use a scanner that can help improve how burns are treated. The draft guidance from the new NICE medical technologies programme provisionally supports the use of moorLDI2-BI, a blood flow imaging device which can help ...
Posted in Health | Comments Off
Thursday, October 7th, 2010
The health authority that advises the government on which drugs should be available under the National Health Service (NHS) in England and Wales has announced a reversal of a 2007 restriction that prevented hundreds of thousands of people with Alzheimer's disease from getting life-changing drugs on the NHS. ...
Posted in Health | Comments Off
Monday, August 16th, 2010
The National Institute for Health and Clinical Excellence (NICE) has issued a final appraisal determination (FAD) on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C, which includes MSD's ViraferonPeg and Rebetol treatment regimen...
Find more info about Nice Final Appraisal Determination Issued For Hepatitis C ...
Posted in Health | Comments Off
